Condition

Gastric Carcinoma clinical trials and research

• 14Clinical trials
• 1New in 30 days
• 6Countries

Newest Gastric Carcinoma clinical trials

All recruiting trials (14)

• PF-08098488 in adults with advanced solid tumors

  This study tests PF-08098488 in adults whose cancer has progressed or returned after prior treatment.

  Recruiting at 4 sites Phase 1 Pfizer · Grand Rapids, Michigan and 3 other locations · NCT07903415

• ENPP1/cGAS and FAP in Solid Tumors in Vietnamese Patients

  This Vietnam-based study will test ENPP1, cGAS, and FAP expression in archived tumor samples from Vietnamese adults with solid cancers using immunohistochemistry.

  Recruiting at 2 sites Tam Anh Research Institute · Hanoi, Hanoi and 1 other locations · NCT07808164

• Microplastic exposure and progression of stomach precancerous changes

  This project will test if adults with higher microplastic exposure are more likely to have precancerous stomach changes or gastric cancer.

  Recruiting Xijing Hospital of Digestive Diseases · Xi'an, Shaanxi · NCT07542652

• Disitamab vedotin plus trastuzumab and tislelizumab versus chemotherapy plus trastuzumab (± pembrolizumab) for HER2‑high advanced gastric or gastroesophageal junction adenocarcinoma

  This trial tests whether combining disitamab vedotin with trastuzumab and the immunotherapy tislelizumab works better than standard chemotherapy with trastuzumab (with or without pembrolizumab) as first‑line treatment for people with HER2‑high advanced gastric or gastroesophageal junction cancer.

  Recruiting Phase 3 RemeGen Co., Ltd. · Beijing, BJ-Beijing · NCT07315750

• Using the PAGODA algorithm to guide FOLFOX dose changes and reduce unplanned chemotherapy delays

  This trial will test whether using the PAGODA algorithm to guide dose changes during FOLFOX chemotherapy for people with gastrointestinal cancers can reduce unplanned treatment delays.

  Recruiting at 391 sites Alliance for Clinical Trials in Oncology · Fairbanks, Alaska and 397 other locations · NCT07283939

• Examining metastatic lymph nodes in each part of the stomach's mesentery during gastrectomy

  This project will see if the number and location of metastatic lymph nodes across the six stomach mesenteries predict outcomes for adults undergoing D2 plus complete mesogastric excision for gastric cancer.

  Recruiting First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang · NCT07139418

• Indocyanine green to highlight tumor depth and margins during endoscopic removal of esophageal or stomach cancer

  This trial will test whether a dye called indocyanine green can help doctors see the depth and edges of superficial esophageal or stomach cancers during endoscopic submucosal dissection.

  Recruiting Phase 1/2 University Medical Center Groningen · Groningen, Provincie Groningen · NCT07108855

• Vanguard: a new blood test approach to screen for multiple cancers

  This study will test two different blood-based multi-cancer detection tests in adults 45–75 without cancer to see if they find cancers earlier than usual care.

  Recruiting at 46 sites National Cancer Institute (NCI) · Pleasanton, California and 45 other locations · NCT06995898

• Checking for lymph node spread and tumor deposits in the posterior gastric mesentery after distal stomach cancer surgery

  This project will check if adults having distal stomach cancer surgery (distal gastrectomy with D2 lymphadenectomy plus complete mesogastric excision) have lymph node metastases or tumor deposits in the posterior gastric mesentery.

  Recruiting First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang · NCT06736847

• Tumor deposits at the fusion of the right and left gastric mesenteries after proximal gastrectomy

  We will see if tumor tissue is present at the fusion site between the right and left gastric mesenteries in adults having proximal gastrectomy for gastric cancer.

  Recruiting First Affiliated Hospital of Zhejiang University · Hangzhou, Zhejiang · NCT06728891

• Examining the relationship between Sintilimab levels and treatment outcomes in advanced gastric cancer patients

  This study is testing how the levels of Sintilimab in the blood affect treatment results and side effects for people with advanced gastric cancer.

  Recruiting Zhongda Hospital · Nanjing, Jiangsu · NCT06702683

• Imaging study using two antibody fragments in patients with solid tumors

  This study is testing two special antibody fragments in people with solid tumors to see how well they target cancer cells and how they move through the body.

  Recruiting Early Phase 1 Var2 Pharmaceuticals · Groningen, Provincie Groningen · NCT06645808

• Evaluating risk factors for stomach cancer

  This study is testing different ways to find out if people aged 40 to 80 from racial minority groups are at high risk for stomach cancer to help catch it early.

  Recruiting City of Hope Medical Center · Duarte, California · NCT06408220

• Using patient-derived cancer models to address health disparities in cancer treatment

  This study is trying to create and test cancer models from patients, especially those from minority backgrounds, to see how we can improve cancer treatments for bladder, gastric, liver, and lung cancers.

  Recruiting at 2 sites University of California, Davis · Orange, California and 1 other locations · NCT04410302

Related topics

Quick answers

How many Gastric Carcinoma clinical trials are recruiting right now?

14, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 6 countries. The most sites are in China (6 trials), United States (5 trials), Netherlands (2 trials), Guam (1 trial), Puerto Rico (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 1, Phase 1/2: 1, Phase 3: 1, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →